| 3.88 Data as of May 24 |  -0.07 / -1.77%Today’s Change | 0.48 Today|||52-Week Range 10.49 | +69.66% Year-to-Date |
| Previous close | 3.95 |
| Today’s open | 3.99 |
| Day’s range | 3.82 - 4.03 |
| Volume | 10,860 |
| Average volume (3 months) | 98,012 |
| Market cap | $16.1M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 4.52 |
| Today’s change | Today’s % change | |
|---|---|---|
| TNXPDTonix Pharmaceutical... | +0.99 | +15.23% |
| TZYMTranzyme Inc | +0.02 | +3.79% |
| DARADARA BioSciences Inc | -0.01 | -1.90% |
| MSLIMerus Labs Internati... | 0.00 | 0.00% |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | $1.4M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Graham E. Kelly, PhD |
Chief Financial Officer Mark G. Hinze, CPA |
Corporate headquarters Sydney, New South Wales (nsw) |
.
